ProfileGDS4718 / 234989_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 96% 93% 98% 97% 96% 96% 95% 97% 98% 95% 98% 85% 97% 93% 97% 94% 96% 95% 95% 96% 93% 93% 98% 98% 93% 98% 98% 98% 94% 94% 92% 98% 96% 97% 91% 93% 97% 93% 88% 93% 98% 98% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.674598
GSM549102patient 115, normal, homogenized [OPG study]10.629596
GSM549104patient 119, normal, homogenized [OPG study]9.7837693
GSM549108patient 138, normal, homogenized [OPG study]11.189798
GSM549119patient 077, normal, homogenized [OPG study]11.107997
GSM549133patient 032, cancer, homogenized [OPG study]10.45296
GSM549139patient 042, cancer, homogenized [OPG study]10.634996
GSM549099patient 107, normal, homogenized [OPG study]10.12495
GSM549109patient 139, normal, homogenized [OPG study]11.098897
GSM549110patient 046, normal, homogenized [OPG study]11.47298
GSM549114patient 063, normal, homogenized [OPG study]10.535495
GSM549122patient 082, normal, homogenized [OPG study]11.537698
GSM549134patient 033, cancer, homogenized [OPG study]8.4527385
GSM549136patient 036, cancer, homogenized [OPG study]10.793697
GSM549140patient 044, cancer, homogenized [OPG study]9.7706693
GSM549111patient 047, normal, homogenized [OPG study]11.183297
GSM549113patient 057, normal, homogenized [OPG study]10.181394
GSM549132patient 031, cancer, homogenized [OPG study]10.349196
GSM549137patient 038, cancer, homogenized [OPG study]10.017495
GSM549142patient 047, cancer, homogenized [OPG study]9.8441395
GSM549100patient 110, normal, homogenized [OPG study]10.716796
GSM549107patient 135, normal, homogenized [OPG study]9.869493
GSM549115patient 068, normal, homogenized [OPG study]9.9431293
GSM549116patient 072, normal, homogenized [OPG study]11.581598
GSM549120patient 078, normal, homogenized [OPG study]11.312698
GSM549131patient 030, cancer, homogenized [OPG study]9.7904693
GSM549118patient 074, normal, homogenized [OPG study]11.389798
GSM549129patient 027, cancer, homogenized [OPG study]10.850598
GSM549123patient 088, normal, homogenized [OPG study]11.641498
GSM549124patient 006, cancer, homogenized [OPG study]9.7299594
GSM549126patient 015, cancer, homogenized [OPG study]9.7994994
GSM549128patient 025, cancer, homogenized [OPG study]9.4547692
GSM549103patient 117, normal, homogenized [OPG study]11.327598
GSM549117patient 073, normal, homogenized [OPG study]10.917596
GSM549138patient 041, cancer, homogenized [OPG study]11.058997
GSM549141patient 045, cancer, homogenized [OPG study]9.470491
GSM549130patient 028, cancer, homogenized [OPG study]9.5853293
GSM549101patient 111, normal, homogenized [OPG study]11.006997
GSM549105patient 128, normal, homogenized [OPG study]9.6497293
GSM549106patient 134, normal, homogenized [OPG study]9.0100888
GSM549112patient 048, normal, homogenized [OPG study]9.7636993
GSM549125patient 011, cancer, homogenized [OPG study]11.47198
GSM549127patient 024, cancer, homogenized [OPG study]11.32698
GSM549135patient 035, cancer, homogenized [OPG study]9.2978390